Equity research analyst Tim Lugo is quoted in an article from Investor’s Business Daily on performance of stocks in the biotech sector, highlighting how big pharma’s interest in biotech companies looks in current market conditions.
Equity Research
Tim Lugo Quoted in Investor’s Business Daily on Biotech Sector Stocks
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
Inari Medical, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Inari Medical, Inc. (NARI $54.73), a medical device company that develops interventional products for patients suffering from venous diseases.
Read moreGifting Appreciated Securities to a Donor-Advised Fund Program
This charitable vehicle provides a simplified approach that allows you to maximize your charitable donations and tax benefits—an approach that can transform the way you give.
Read moreClio Valued at $3B in $900M Series F Investment Led by NEA
William Blair acted as the exclusive financial advisor to Clio in connection with its $900 million Series F investment round led by New Enterprise Associates, at a $3.0 billion valuation.
Read more